Lisa Peraza
Net Worth

Last updated: 13 Jan 2024

What is Lisa Peraza net worth?

The estimated net worth of Ms. Lisa Peraza is at least $1,796,240 as of 13 Jan 2024. She has received compensation worth at least $1,796,240 in Heron Therapeutics, Inc..

What is the salary of Lisa Peraza?

Ms. Lisa Peraza salary is $449,060 per year as Vice President & Chief Accounting Officer in Heron Therapeutics, Inc..

How old is Lisa Peraza?

Ms. Lisa Peraza is 48 years old, born in 1977.

Lisa Peraza insider trading

Heron Therapeutics, Inc.

Transaction	Date	Security	Shares	Price per share	Total value
Option	13 Jan 2024	Common Stock	1,289	N/A	N/A
Option	13 Jan 2024	Restricted Stock Units	1,289	N/A	N/A
Option	13 Jan 2024	Common Stock	552	N/A	N/A
Option	13 Jan 2024	Restricted Stock Units	552	N/A	N/A
Option	13 Oct 2023	Common Stock	552	N/A	N/A
Option	13 Oct 2023	Restricted Stock Units	552	N/A	N/A
Option	13 Oct 2023	Common Stock	1,932	N/A	N/A
Option	13 Oct 2023	Restricted Stock Units	1,932	N/A	N/A
Option	13 Jul 2023	Common Stock	552	N/A	N/A
Option	13 Jul 2023	Restricted Stock Units	552	N/A	N/A
Option	13 Jul 2023	Common Stock	1,933	N/A	N/A
Option	13 Jul 2023	Restricted Stock Units	1,933	N/A	N/A
Option	13 Apr 2023	Common Stock	1,932	N/A	N/A
Option	13 Apr 2023	Restricted Stock Units	552	N/A	N/A
Option	13 Apr 2023	Restricted Stock Units	1,932	N/A	N/A
Option	13 Apr 2023	Common Stock	552	N/A	N/A
Option	13 Jan 2023	Common Stock	1,933	N/A	N/A
Option	13 Jan 2023	Restricted Stock Units	552	N/A	N/A
Option	13 Jan 2023	Restricted Stock Units	1,933	N/A	N/A
Option	13 Jan 2023	Common Stock	552	N/A	N/A
Option	13 Oct 2022	Restricted Stock Units	553	N/A	N/A
Option	13 Oct 2022	Common Stock	553	N/A	N/A
Option	13 Oct 2022	Common Stock	1,932	N/A	N/A
Option	13 Oct 2022	Restricted Stock Units	1,932	N/A	N/A
Option	13 Jul 2022	Restricted Stock Units	552	N/A	N/A
Option	13 Jul 2022	Common Stock	1,933	N/A	N/A
Option	13 Jul 2022	Restricted Stock Units	1,933	N/A	N/A
Option	13 Jul 2022	Common Stock	552	N/A	N/A
Option	13 Apr 2022	Restricted Stock Units	552	N/A	N/A
Option	13 Apr 2022	Common Stock	552	N/A	N/A
Option	13 Apr 2022	Common Stock	1,932	N/A	N/A
Option	13 Apr 2022	Restricted Stock Units	1,932	N/A	N/A
Option	13 Jan 2022	Common Stock	1,933	N/A	N/A
Option	13 Jan 2022	Common Stock	552	N/A	N/A
Option	13 Jan 2022	Restricted Stock Units	1,933	N/A	N/A
Option	13 Jan 2022	Restricted Stock Units	552	N/A	N/A
Option	13 Oct 2021	Restricted Stock Units	552	N/A	N/A
Option	13 Oct 2021	Common Stock	552	N/A	N/A
Option	13 Jul 2021	Common Stock	552	N/A	N/A
Option	13 Jul 2021	Restricted Stock Units	552	N/A	N/A
Option	13 Apr 2021	Restricted Stock Units	552	N/A	N/A
Option	13 Apr 2021	Common Stock	552	N/A	N/A
Option	13 Jan 2021	Restricted Stock Units	552	N/A	N/A
Option	13 Jan 2021	Common Stock	552	N/A	N/A

Heron Therapeutics key executives

Heron Therapeutics, Inc. executives and other stock owners filed with the SEC:

Dr. Barry D. Quart (68) Chairman & Chief Executive Officer
Mr. David L. Szekeres (51) Executive Vice President & Chief Operating Officer
Mr. John W. Poyhonen (65) Pres & Chief Commercial Officer
Ms. Kimberly J. Manhard (65) Executive Vice President of Drug Devel. & Director
Ms. Lisa Peraza (48) Vice President & Chief Accounting Officer

Lisa Peraza Net Worth